SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are experiencing strong momentum following a Bloomberg report that the company is exploring strategic options, including a potential sale. The market is buzzing with speculation about a possible bidding war involving major media and tech firms, while community members weigh the stock's recent technical breakout against the challenges of a competitive streaming landscape.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is gaining significant traction as Ripple expands its institutional footprint through major partnerships with global financial giants and the continued growth of tokenized real-world assets on the XRP Ledger. The community is actively discussing this institutional shift, bolstered by positive regulatory momentum and the rapid development of the RLUSD stablecoin ecosystem, fueling speculation about long-term adoption.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is currently facing significant selling pressure and volatility, with the community actively debating whether the stock's sluggish performance is a result of sector-wide headwinds, algorithmic trading, or a lack of visibility on contract value. While some investors are accumulating shares in anticipation of long-term upside from nuclear and government infrastructure projects, others remain frustrated by persistent late-day selloffs and limited price momentum.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the company secures multiple high-profile defense and energy contracts, including SMR agreements in the Czech Republic and propulsion deals for international naval fleets. The community is actively discussing the stock's resilience amidst geopolitical volatility and its long-term potential as a key player in global energy and defense infrastructure.

Chip

Chip is trending as investors debate its role as a GPU-backed lending protocol amid significant price volatility and ongoing arguments between those betting on its AI infrastructure utility and others calling it a pump-and-dump scheme. The community is actively tracking its protocol fees and loan pipeline while speculating on whether recent price action represents a bear trap or a continued downward trend.

The Coca-Cola Co. engages in the manufacturing and marketing of non-alcoholic beverages. It operates through the following segments: Europe, Middle East and Africa, Latin America, North America, Asia Pacific, Global Ventures, and Bottling Investments. The company was founded by Asa Griggs Candler on May 8, 1886 and is headquartered in Atlanta, GA.

Coca-Cola Co

Coca-Cola is currently trending as a defensive rotation play, driven by investors seeking a safe haven amidst broader market volatility and uncertainty. The community is actively debating the company's valuation against its dividend consistency, with sentiment split between those viewing it as a stable long-term compounder and those concerned that the stock is becoming overextended.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors digest the company's recent strategic partnership with AWS to provide private, high-speed last-mile cloud connectivity. The community is actively debating the company's long-term transformation into an AI-infrastructure powerhouse, with many focused on the potential for massive network demand and the strategic shift away from legacy telecom services.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors digest the impact of a 1-for-10 reverse stock split and a strategic shift toward lower-volatility, large-cap holdings intended to stabilize net asset value. Community sentiment remains polarized, with debates centering on whether the revamped portfolio and ongoing weekly distributions can counteract persistent NAV decay versus the risks of further share price erosion.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors react to the company's announcement of a stock offering alongside positive clinical trial data, with community debate centered on whether this dilution is a necessary step for commercialization or a setback for shareholders. While some are concerned by the offering's impact on share price and short-term volatility, others remain focused on the long-term potential of the company's gene-editing platform and significant institutional support.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl is currently trending due to intensifying scrutiny of the private credit sector, characterized by rising redemption requests and concerns regarding loan quality. Community discussions reflect a polarized sentiment, with some investors leveraging the price weakness as a deep-value opportunity while others warn of broader liquidity risks and potential systemic exposure to the software industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novartis Reports Positive Data for Neuromuscular Disorder Drug 

NVS announces positive FORTITUDE data as del-brax met key endpoints, supporting its potential as a disease-modifying treatment for FSHD.

EMA Begins Review of Bayer's Asundexian Filing for Stroke Prevention

BAYRY's asundexian enters EMA review for stroke prevention after phase III data showed a 26% cut in ischemic stroke without more major bleeding.

BAYRY or RHHBY: Which Is the Better Value Stock Right Now?

BAYRY vs. RHHBY: Which Stock Is the Better Value Option?

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength (Revised)

REGN tops Q1 estimates with strong Dupixent and Eylea HD growth, but the stock slips as Eylea sales plunge and competition intensifies.

Here's Why Investors Must Hold IQV Stock in Their Portfolios for Now

IQVIA's record $34.2B backlog, AI-led pharma demand and $1.24B buybacks support growth despite weak liquidity and no dividend.

Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer

Eli Lilly, Johnson & Johnson, Novo Nordisk and Bayer are benefiting from innovation, pipeline growth and strong demand in key therapies.

4 Large-Cap Pharma Stocks to Buy as Industry Recovery Accelerates

In the Large-Cap Pharmaceuticals industry, LLY, J&J, NVO and BAYRY are worth retaining as the industry shows some recovery.

BAYRY's Kerendia Label Expansion Application Gets Priority Review 

Bayer wins FDA Priority Review for Kerendia label expansion in CKD tied to type I diabetes after strong phase III data.

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

REGN teams up with Parabilis in a potential $2.2B deal to develop Antibody-Helicon Conjugates targeting hard-to-treat cancers.

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

BAYRYBayer AG (ADR)

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BAYRY News